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Abstract
Background—Many studies have shown a U-shape association between sleep duration and
mortality, but epidemiological evidence linking cardiovascular diseases (CVD) with habitual sleep
patterns is limited and mixed.
Methods—We conducted a prospective study on 93175 older women (aged 50–79 years) in the
Women’s Health Initiative Observational Study cohort to examine the risk of ischemic stroke in
relation to self-reported sleep duration. Cox models were used to investigate the putative associations,
adjusting for multiple sociodemographic and lifestyle factors, depression, snoring, sleepiness
symptoms, and other CVD-related clinical characteristics.
Results—At baseline, 8.3% of subjects had their reported sleep duration ≤5h/night and 4.6% with
long sleep (≥9h/night). After an average of 7.5 years of follow-up, 1166 cases of ischemic stroke had
occurred. Multivariable-adjusted relative risks (RR; 95% confidence intervals) for ischemic stroke
(using a sleep time of 7h/night as the reference) were 1.14 (0.97, 1.33), 1.24 (1.04, 1.47) and 1.70
(1.32, 2.21) for women reporting 6 or less, 8, and 9 or more hours of sleep. A modestly stronger
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association with sleep duration ≤ 6h/night (RR=1.22; 1.03, 1.44) was noted among women without
prevalent CVD at baseline. Our analyses also reveal that the adverse effect of long sleep is likely
independent of the increased risk for ischemic stroke associated with frequent snoring and sleepiness
(RR=1.31; 1.00, 1.72).
Conclusions—Habitual sleep patterns are important neurobehavioral determinants of risk for
ischemic stroke in postmenopausal women. The underlying neurobiology and mechanistic mediators
for the putative adverse effect of long sleep (≥9h/night) need further elucidation.
Keywords
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INTRODUCTION
Increases in mortality associated with either shortened sleep (sleep duration ≤6 h/night) or long
sleep duration (sleep duration ≥9 h/night) have consistently been found in many population-
based studies.1–3 What accounts for this association is not fully understood. Three previous
studies, the follow-up of First National Health and Nutrition Examination Survey (NHANES-
I) participants, the Nurses’ Health Study (NHS), and the Monitoring Trends and Determinants
on Cardiovascular Diseases (MONICA) Augsburg cohort study, have investigated the putative
effect of habitual sleep duration on the risk of coronary heart disease (CHD), with mixed results.
4–6 Both the NHS and NHANES-I follow-up study reported an increased CHD risk associated
with habitual sleep duration less than 6 hours, which also increased the MI risk among middle-
aged women in the MONICA Augsburg cohort. Long sleep duration (≥9 h/night) was
associated with increased CHD risk in the NHS, but it was associated with statistically non-
significant increase in MI risk among women in the recent MONICA Augsburg cohort analysis,
with no association found in NHANES-I follow-up study. Epidemiological data relating
habitual sleep duration to the risk of stroke are very sparse, and only the NHANES-I follow-
up study reported an increased risk of stroke in long sleepers (>8h), but not in short sleepers
(<6h).6 Causal inference cannot be drawn from theses studies, and the reported analyses did
not fully account for potential confounding by individual attributes that are common
determinants of both sleep duration and risk of cardiovascular diseases (CVD), such as race/
ethnicity, socioeconomic position, lifestyle factors, and depressive symptoms.7,8 Although
some studies on mortality1, 3 have reported a larger effect size for long sleep than for short
sleep, it has been argued that the observed detrimental health effects of long sleep are likely
confounded by depression or socioeconomic status (e.g., unemployment status).9 In addition,
previous studies did not distinguish ischemic stroke from hemorrhagic events, even though
there is little neurobiological rationale to suggest that hemorrhagic stroke would be associated
with either short or long sleep duration.
To address the above-mentioned uncertainty in relating sleep duration to increased risk of
stroke, we conducted a longitudinal analysis focusing primarily on ischemic stroke, using the
comprehensive data from the Women’s Health Initiative Observational Study (WHI-OS), a
long-term (1994–2005) prospective cohort study designed to identify and assess the
relationships of biological, lifestyle, biochemical, and genetic factors to the risks of heart
disease, cancer, osteoporosis, and other major health problems of older women.
METHODS
Study Population
Detailed information about the study population, recruitment methods, and measurement
protocols of the WHI-OS has been published previously.10, 11 Briefly, the WHI-OS
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population is a multiethnic cohort (0.5% American Indian–Alaskan Native, 8.2% African
American, 2.9% Asian–Pacific Islander, 3.9% Hispanic, 83.3% white, and 1.4% unknown) of
93,676 women, who were aged 50–79 at study inception and recruited from the areas
surrounding 40 clinical centers in 24 states and District Columbia, between September 1, 1994
and December 31, 1998. The recruitment areas covered a variety of communities including
urban, suburban, and rural populations. Women were eligible to participate in WHI-OS if they
were postmenopausal, unlikely to change residence or die within 3 years of enrollment; did
not have complicated conditions such as alcoholism, drug dependence, or dementia; and were
not enrolled in the WHI or any other clinical trials. Participants entered the WHI-OS by
expressing initial interest in either the diet modification or hormone therapy arms of the WHI
Clinical Trials (WHI-CT) but proved ineligible or unwilling to participate or responded to a
direct invitation to be screened for the WHI-OS. All participants provided written informed
consent, approved by the institutional review board of each participating center.
Study Variable
The measures of sleep disturbance in WHI cohort were developed by sleep researcher
consultants to the WHI Behavioral Advisory Committee. As part of the baseline examination,
each WHI participant was asked to report “hours of sleep on a typical night during the past 4
weeks” (≤5, 6, 7, 8, 9, ≥10). Levine and colleagues have assessed the psychometric properties
of these sleep measures and noted that sleep duration did not strongly correlate with other
construct of sleep disturbance, such as insomnia.12 Analyses of their data also indicated very
good test-retest reliability for both self-reported sleep duration (Spearman R=0.97 for same-
day administration and 0.89 for 8–14 days).
Ascertainment of Health Outcome
The diagnosis of ischemic stroke followed the established protocols that have been published
elsewhere.13,14 In brief, potential stroke outcomes in WHI-OS, including fatal and non-fatal
events, were queried initially through self-reports at annual contacts. When a potential outcome
was identified, medical records and death certificates were requested and assembled. The
diagnosis of stroke was based on rapid onset of a persistent neurological deficit attributed to
the brain arterial system lasting more than 24 hours (unless death supervenes) without evidence
for other cause, such as brain trauma, tumor, or infection, etc. Stroke outcomes were classified
as ischemic stroke, if the clinical diagnosis revealed the occlusion of cerebral or pre-cerebral
arteries with infarction (cerebral thrombosis, cerebral embolism, lacunar infarction). Cases
with hemorrhagic stroke or other acute but ill-defined cerebrovascular diseases and those
resulting from iatrogenic complications were considered as non-ischemic stroke in the present
study. At each clinical center, the local physician adjudicator reviewed the medical records
and, using these standardized criteria, determined the diagnosis of ischemic stroke. The
estimated proportion of WHI stroke case classification based on CT or MRI findings was high
(>95%), and there were only few cases that were classified according to the specific clinical
information (e.g., surgical evidence) or did not have neuroimaging studies available (e.g., fatal
strokes). In a subset of locally-adjudicated ischemic stroke cases (n=926) called for central
review, 91% agreed with central adjudication.
Measurement of Pertinent Covariates
At the baseline visit, participants completed structured questionnaires to solicit information on
demographic features, socioeconomic status, lifestyle factors (e.g., smoking, physical activity),
and relevant clinical characteristics, including use of menopausal hormone therapy (HT), prior
histories of CHD/CVD and related clinical risk factors. Physical measures of weight, height
and blood pressure were taken at baseline. Individuals were classified into the following body
mass index (BMI, in kg/m2) categories: Underweight (<18.5), Normal (18.5–24.9),
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Overweight (25.0– 29.9), Obesity I (30.0–34.9), Obesity II (35.0–39.9), and Obesity III (≥40).
Hypertension was defined as having a physician diagnosis plus receiving medications, or
having elevated blood pressure (systolic ≥140, diastolic ≥ 90 mm-Hg, or both). Women were
classified as having treated diabetes mellitus (DM), if they had a physician diagnosis plus
receiving oral medications or insulin. CHD was defined as having prior MI, coronary
angioplasty, or coronary artery bypass graft (CABG). Histories of CVD include having
previous CHD, stroke, or transient ischemic attack (TIA). Good reliability and validity of these
self-reported clinical characteristics and physical measures have been documented.11, 15
Depressive symptoms were assessed with a scale that used 6 items from the 20-item Center
for Epidemiological Studies Depression Scale (CES-D).16 The 6-item CES-D included one
item about poor sleep (“Your sleep was restless”). To avoid colinearity between measures of
sleep measures and depressive symptoms, we excluded one item about poor sleep (“Your sleep
was restless”) and used the 5-item CES-D score to adjust for the effect of depressive symptoms
in our main analyses. Two items from the Diagnostic Interview Schedule17 were used to assess
feelings of sadness or depression for 2 or more weeks in the past year and feelings of sadness
on most days for 2 or more years. Subjects responding “yes” to both items were classified as
having “history of depression.” The participants also rated the frequency of snoring (“Did you
snore”) and sleepiness (“falling asleep during quiet activities like reading, watching TV, or
riding in a car”), based on a 5-point scale (0, <1, 1–2, 3–4, ≥5 times per week) over the past
4 weeks, with an additional choice of “Don’t know” for self-reported snoring. We classified
participants as having frequent snoring or sleepiness if they reported more than once per week
of indicated sleep disturbance. There was also good test-retest reliability for the frequency of
snoring (Spearman R=0.98 for same-day administration and 0.81 for 8–14 days).
Statistical Analyses
We compared the distributions of sleep duration across different population characteristics,
using chi-square tests. Follow-up time for each woman was accrued from enrollment to the
event date with ischemic stroke, loss to follow-up, or the end of current study on September
12, 2005, whichever came first. Accordingly to the WHI protocol, women who had developed
non-ischemic stroke during the follow-up would not enter adjudication again. Although non-
ischemic stroke is not the outcome of interest in the present analyses, these women were also
censored at the time of non-ischemic stroke. Based on the time-to-event analyses, crude event
rates were then calculated and compared across subgroups with different sleep duration. Cox
proportional hazard models were used to estimate hazard ratios for having ischemic stroke
associated with habitual sleep duration, adjusting for potential confounders. A full set of
participants characteristics were included in the multivariable analyses regardless of their
respective associations with ischemic stroke in our study population, including: age, race-
ethnicity, socioeconomic status (education, family income, employment), lifestyle factors
(smoking, physical activity), depressive symptoms, HT usage, and other clinical characteristics
(prior CVD, hypertension, DM, high cholesterol level requiring medication, and obesity). We
also stratified the effect estimates by clinical characteristics, to assess whether the putative
effects persist in those without prior comorbid conditions (CVD/CHD, DM, hypertension)
predisposing to sleep disturbance and the study endpoint.
Several sensitivity analyses were carried out to evaluate whether the observed associations
were sensitive to excluding ischemic stroke events which incurred during the early course
(within the first 6 months) of follow-up, including 6-item CES-D score, or further accounting
for history of depression in the multivariable-adjusted models. Additional analyses jointly
modeling the effect of habitual sleep duration and “frequent snoring and sleepiness” were also
conducted to explore the independent effects of different subconstructs of sleep disturbance.
All these statistical analyses were performed using the SAS System for Windows, version 9
(SAS Institute, Cary, NC).
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Table 1 presents the population distribution of sleep duration in relation to selected baseline
(1994–1998) sociodemographics and lifestyle factors. Approximately 8.3% reported short
sleep duration ≤5h/night, while 4.6% were long sleepers (≥9h/night). A higher proportion of
minority women had short sleep, compared to 6.7% of White, as follows: Black (19.0%),
Hispanic (13.8%), American Indian (14.8%) and Asian/Pacific Islander (14.9%). Low
socioeconomic status (educational attainment; family income) was associated with high
prevalence of short sleep duration ≤5h/night. Prevalence of short sleep duration ≤5h/night was
much higher in women who were physically inactive, when compared to their counter parts.
The prevalence of being long sleepers (≥9h/night) also differed by individual socioeconomic
status. There was also a graded increase in the prevalence of being long sleepers as the family
income decreased. Women who retired or were not currently working were more likely than
employed women to have long sleep duration. Being current smokers or less physically active
was associated with a slightly higher prevalence of being long sleepers.
As shown in Table 2, clinical characteristics were important determinants of sleep duration.
Increasing BMI, up above normal (18.5–24.9 kg/m2), was associated with increased prevalence
of short sleep duration ≤5h/night. Current HT users were less likely to have short sleep than
non-current users. Participants with existing CHD/CVD, treated DM, hypertension,
hypercholesterolemia, or depression were more likely to report short sleep duration ≤5h/night
than those without these comorbid conditions. Women with existing CHD/CVD, treated DM,
hypertension, hypercholesterolemia, or depressive symptoms were more likely to have long
sleep duration than those without these comorbid conditions, although such differences were
not as prominent as those seen in the prevalence of having short sleep duration ≤5h/night.
We noted that self-reported sleep duration had a non-linear relation with the frequency of
snoring as well as with the frequency of sleepiness. Compared to women in the other categories
of sleep duration, women with 8–9h of sleep were the least likely to have frequent sleepiness
(42–44% vs. 48–61%) and women with 7h of sleep were the least likely to report frequent
snoring (20% vs. 21–30%). Higher prevalence of having both “frequent snoring and sleepiness”
was found in participants with 5 hours or less of sleep (15%) or 10 hours or more of sleep
(17%), compared to the others (11–14%).
A total of 1166 cases of ischemic stroke occurred during an average of 7.5 years of follow-up.
There was a suggested U-shape relation between sleep duration and risk of ischemic stroke
(Table 3). Women with sleep duration=7h/night had the lowest risk for ischemic stroke; the
risk was higher in women with sleep≤6h/night and a graded increase in risk was noted for
women with increasing sleep duration beyond 7h/night. Given the relatively small number of
cases among those with longest (n=15 in those with sleep≥10h/night) or shortest sleep (n=99
in those with short sleep duration ≤5h/night), we combined these two distributional extremes
with their adjacent categories in the further adjusted analyses. Results of the multi-variable
adjusted Cox models were also presented in Table 3. Using women with sleep duration=7h/
night as the referent, we found a 19% (95% confidence interval [CI]: 3–37%) increase in
relative risk (RR) in women with sleep ≤ 6h/night, after adjustment for age and race. However,
the increased RR associated with sleep duration ≤ 6h/night was slightly diminished and became
statistically non-significant (Model-IV: RR=1.14, 95%CI: 0.97, 1.33) after additionally
accounting for socioeconomic status, depressive symptoms, HT use, and conventional CVD
risk factors. In contrast, there was a consistent and graded increase in RR observed for women
with sleep=8h/night and for those with sleep≥9h/night. These elevated RRs among women
with sleep duration above 7h/night remained fairly stable in all the adjusted models, with the
RR increased approximately by 25% among women with sleep duration=8h/night and by 70%
in those with sleep≥9h/night. We also noted the increase in ischemic stroke risk among women
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with frequent snoring and sleepiness. Compared to those reporting no or <1/week in both
snoring and sleepiness, women with both “frequent snoring and sleepiness” had an elevated
but statistically non-significant risk for ischemic stroke (RR=1.28, 95%CI: 0.98–1.68),
adjusting for the same set of confounders in Model-IV, with a stronger association (RR=1.51,
95%CI: 1.11, 2.06) noted in women without prevalent CVD.
We found only very little changes to the effect estimates (comparing either short- or long-
sleepers to those with sleep=7hrs/night) and the U-shape relationship between habitual sleep
patterns and ischemic stroke remained in the sensitivity analyses. After we excluded the events
which occurred within the first 6 months of follow-up, an increased risk for ischemic stroke
was observed among participants reporting 6-h or less (RR=1.15, 95%CI: 0.98–1.35), 8-h
(RR=1.22, 95%CI: 1.03–1.45), and 9-h or more (RR=1.71, 95%CI: 1.32–2.23), adjusting for
the same set of confounders in Model-IV. In the multivariable-adjusted model including 6-
item CES-D, we still observed an increased risk for ischemic stroke in short sleepers (RR=1.15,
95%CI: 0.98–1.36) and in those with sleep duration=8h (RR=1.21, 95%CI: 1.02–1.44) or ≥9h
(RR=1.71, 95%CI: 1.32–2.22).
Similarly, after we substituted the “depressive symptoms” with “history of depression” in the
multivariable-adjusted analyses, an increased risk for ischemic stroke remained for women
reporting 6-h or less (RR=1.11, 95%CI: 0.95–1.30), 8-h (RR=1.22, 95%CI: 1.03–1.45), and
9-h or more (RR=1.60, 95%CI: 1.23–2.08). In our exploratory analysis which jointly modeled
the presumably independent effects of “frequent snoring/sleepiness” and habitual sleep
duration, the modest increase in risk was still noted in short sleepers (RR=1.14, 95%CI: 0.97–
1.35), and there were statistically significant associations both with long sleep (RR=1.66, 95%
CI: 1.27, 2.16) and with “frequent snoring and sleepiness” (RR=1.31, 95%CI: 1.00, 1.72).
In Table 4, the estimated associations with habitual sleep patterns were furthered stratified by
the presence of prior CVD/CHD, DM, or hypertension. The increased RRs for ischemic stroke
in women with sleep≥9h/night were very consistent and did not depend upon these clinical
comorbidities. The positive association with sleep ≤ 6h/night remained among those without
the indicated comorbidities predictive of sleep deprivation, and the modest increase in RR of
ischemic stroke became statistically significant among women without existing CVD
(RR=1.26, 95%CI: 1.06, 1.50) or DM (RR=1.22, 95%CI: 1.03, 1.44) at baseline.
DISCUSSION
Our study results corroborate and extend the previous observation of Qureshi and colleagues
in the NHANES-I follow-up study.6 In their 10-year longitudinal analyses of the national
cohort of 7844 adults (aged 25–74 at baseline), long sleepers (>8 h/night) had increased stroke
risk (RR=1.5, 95% CI: 1.1–2.0), compared to those with sleep 6–8 h/night. However, the
ascertained outcome in the NHANES-I did not differentiate between ischemic and hemorrhagic
stroke events, and the reported association with long sleep did not adjust for the potential
confounding by income, physical activity level and depressive symptoms. Indeed, we found
that income, physical activities, depressive symptoms, and other CVD risk factors were all
important correlates of sleep duration in postmenopausal women (Table 1 & 2). Nonetheless,
results of our adjusted analyses (Table 3) suggested that these factors could only account for
part of the positive association between ischemic stroke and habitual sleep patterns. Previous
analyses of NHANES-I data did not show an increased risk of stroke in short sleepers, although
there were only a small number of stroke events (n=26 in 675 subjects with sleep <6 h/night)
in a likely less vulnerable study population (> 50% younger than 52 years), with subjects
reporting 6 hours of sleep included in the referent and less rigorous requirements for stroke
case ascertainment than the WHI protocols.
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We found an association of ischemic stroke (~60–70% increase in risk) with long sleep that
was stronger than the association with short sleep (~10–20% increase in risk), and such a
difference was present in all our adjusted analyses, regardless of clinical comorbidities
predictive of habitual sleep patterns (Table 3). This was consistent with previous studies
showing that the effect size of long sleep on mortality was larger than that of short sleep.1, 3
With long sleep duration there was increased CHD risk in the NHS5 and MI risk in the
MONICA Augsburg cohort.4 It had been speculated that the increased risks for CHD, stroke,
and mortality among long sleepers might be due to other sleep disorders, such as sleep-
disordered breathing (SDB).3,6. We categorized women who reported both frequent snoring
and sleepiness as having SDB-related symptoms and found that women with 10 or more hours
of sleep had the highest prevalence of SDB-related symptoms, and the risk of ischemic stroke
was increased in women with frequent snoring/sleepiness. However, our exploratory analysis
which jointly modeled the effects of sleep duration and frequent snoring/sleepiness supported
the putative effect of long sleep independent of SDB-related symptoms.
The reported detrimental health effects of long sleep have also been attributed to the potential
confounding by depression.7,9 Having prior histories of depression was an important
determinant of habitual sleep duration (Table 2), and increased risk of stroke was documented
in WHI-OS participants with depressive symptoms or prior depression.18 However, in our
sensitivity analyses which included the 6-item CES-D score in the multivariable-adjusted
model or accounted for the history of depression, we still observed a statistically significant
increase (by ~60–70%) in ischemic stroke risk among long sleepers.
The demonstrated consistent association of increased risk of ischemic stroke with long sleep
raises the question of underlying mechanisms. If long sleep duration is part of the prodromal
complex of subsequent stroke symptoms, there would have been an attenuated association in
the sensitivity analyses excluding cases accrued in the first 6 months of follow-up. Another
possibility is that long sleep duration may also reflect some unmeasured socio-behavioral
attributes, environmental factors, or underlying biophysical constructs that are proximate
causes of ischemic stroke. Given the strength of association and low prevalence of long
sleepers, if such unmeasured confounders exist, they need to be strong predictors of long sleep
and increase the risk of ischemic stroke to a large extent not mediated by those CVD risk factors
included in our analyses. Because our multi-variable models have included a large set of
sociodemographic features, lifestyle factors, and clinical characteristics, it is unlikely that the
observed consistent increase in ischemic stroke risk in long sleepers is entirely due to
unmeasured confounding. Provided that long sleep duration is an independent neurobehavioral
risk factor for ischemic stroke, at least in postmenopausal women, what exactly predisposes
long sleepers to be more likely to develop ischemic stroke than those usually with 7 hours of
sleep? Previous studies have found increased risks of diabetes and hypertension in people sleep
≥9h/night.19, 20 These plausible links with diabetes and hypertension, however, could not
fully explain the increased risk for ischemic stroke among long sleepers in the WHI-OS, since
our analyses have accounted for a large set of conventional CVD risk factors. Are long sleepers
more likely to have systemic inflammation, thrombostatic abnormalities, and endothelial
dysfunction, making them more susceptible to the development and progression of
atherosclerosis and subsequent ischemic stroke? Can habitual long sleep duration reset the
individual’s circadian pacemaker into a chronobiological state with neurocardio-
electrophysiologic excitability predisposing to cardiac arrhythmia? Does the longer than
average duration of recumbent position increase the period with high intracranial pressure and/
or alter hemodynamics that can compromises the cerebral blood flow? Sound epidemiologic
and laboratory data are needed to explore these hypotheses in order to establish the
neurobiological basis and identify the mechanistic mediators underlying the detrimental health
consequence of long sleep duration.
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The modest increase in ischemic stroke risk associated with short sleep (≤6h/night), among
those without previous CVD, supports the growing evidence of long-term adverse effects of
sleep deprivation. If we considered short sleep duration≤5h/night equivalent to sleep <6h as
often classified and reported by others, the prevalence (8.3%) of having short sleep duration
among older women aged 50–79 years in 1994–1998 was much less than the estimated
prevalence (14%) of having weekday sleep <6h/night for women aged 55–84 included in the
2003 Sleep in America poll, conforming to the notion of a downward trend in sleep duration
over time.8 Population-based data have previously shown that insufficient sleep increases the
risks for mortality, obesity, DM, hypertension, and CHD. Clinical laboratory studies have
found that sleep deprivation causes neuroendocrine disturbance, metabolic abnormalities, and
systemic inflammation, all indicative of increased risk of atherosclerosis.8 Given these
congruent lines of evidence all pointing to the adverse health consequence of sleep deprivation,
appropriate behavioral intervention should be considered.
We recognized several limitations in our study. First, the WHI-OS is restricted to
postmenopausal women. Although there is suggested evidence that women may be more
susceptible to the detrimental health effects of sleep deprivation,4 there remains uncertainty
in the speculated gender-specific difference. Whether the risks of ischemic stroke in younger
women and in men also depend on sleep duration needs to be investigated. Second, no objective
measures of sleep duration were available in the WHI-OS, and our classification of habitual
sleep duration is based on self-reports at baseline. However, it has been shown that objective
sleep measures have a much larger nightly variability of sleep duration than its corresponding
yearly variability,21 suggesting that sleep behavior changes little in one year, despite large
daily fluctuations. Good reproducibility of exposure classification of self-reported habitual
sleep duration has also been documented in large cohort studies.2,3 Given our prospective
study design, it is more likely that the subjective measure of sleep duration will lead to non-
differential misclassification, which tends to bias the association towards the null. Third,
although we have included a large set of potential confounders in our analyses, we could not
completely rule out the possibility of any residual or unmeasured confounding. This is a more
legitimate concern regarding the modest association with short sleep, as its estimated effect
size was gradually attenuated in the adjusted analyses. For instance, short sleep duration could
result from occupational stressors or concurrent stressful life events, and these psychosocial
stressors may lead to ischemic stroke by alternative pathways other than through the mediation
of conventional CVD risk factors or associated lifestyle modification.
SUMMARY
In postmenopausal women, long sleep duration (≥9h/night) increases the risk for ischemic
stroke. This association is not confounded by socioeconomic status, depressive symptoms, or
other conventional CVD risk factors, and is likely independent of the effect of frequent snoring
and sleepiness. The underlying neurobiology and mechanistic mediators linking habitual long
sleep with increased risk of ischemic stroke need to be investigated. Our data also suggest short
sleep duration (≤6h/night) as a neurobehavioral risk factor for ischemic stroke in
postmenopausal women without clinically overt CVD.
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Table 4
The Associations of Ischemic Stroke Risk with Sleep Duration in WHI-OS, Stratified by Baseline Comorbidities.
Prior CVD Prior CHD
Yes (N=5877) No (N=85896) Yes (N=3215) No (N=88525)
Sleep duration Hazard Ratios or Relative Risks (95% confidence interval)*
     ≤ 6 hrs 0.75 (0.53, 1.07) 1.26 (1.06, 1.50) 0.84 (0.52, 1.37) 1.19 (1.00, 1.40)
     7 hrs 1.00 1.00 1.00 1.00
     8 hrs 1.23 (0.84, 1.79) 1.24 (1.02, 1.50) 1.03 (0.58, 1.83) 1.26 (1.05, 1.51)
     ≥ 9 hrs 1.76 (1.05, 2.95) 1.66 (1.24, 2.24) 1.69 (0.77, 3.68) 1.73 (1.31, 2.27)
     p-value† 0.03 0.60
Diabetes Mellitus Hypertension
Yes (N=3867) No (N=89189) Yes (N=35967) No (N=56122)
Sleep duration Hazard Ratios or Relative Risks (95% confidence interval)*
     ≤ 6 hrs 0.68 (0.43, 1.07) 1.22 (1.03, 1.44) 1.11 (0.92, 1.36) 1.19 (0.92, 1.54)
     7 hrs 1.00 1.00 1.00 1.00
     8 hrs 1.13 (0.69, 1.84) 1.25 (1.04, 1.50) 1.34 (1.09, 1.65) 1.05 (0.78, 1.41)
     ≥ 9 hrs 1.74 (0.90, 3.33) 1.68 (1.27, 2.23) 1.59 (1.14, 2.20) 1.92 (1.27, 2.91)
     p-value† 0.07 0.29
*
all effect estimates adjusted for age, race, socioeconomic status (education, family income, employment), depression, smoking, exercise, use of hormone
therapy, and relevant CVD risk factors (prior CVD/CHD, DM, hypertension, high cholesterol levels requiring pills, BMI). CVD/CHD: defined in Table
2
†
p-value comparing the RR with potential effect modifier present vs. RR with potential effect modifier absent
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